Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedAdds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment header formatting, plus a revised version tag (Revision: v3.6.0). It also states that the study is no longer recruiting participants.SummaryDifference0.3%

- Check11 days agoChange DetectedThe revision tag on the page changes from v3.5.4 to v3.5.5, indicating a software/maintenance update to the site. It does not modify study content or other user-visible information.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a backend/metadata change. There is no indication of changes to the visible content or layout.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s footer revision label has been updated from **v3.5.2** to **v3.5.3**, reflecting a minor update to the site software/display version without altering the underlying study record details.SummaryDifference0.0%

- Check60 days agoChange DetectedCurrent revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded medullary thyroid carcinoma to the conditions list and included Genetic and Rare Diseases Information Center as a resources link.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.